Controlled drug delivery from composites of nanostructured porous silicon and poly(L-lactide)

被引:0
|
作者
McInnes, Steven J. P. [1 ]
Irani, Yazad [2 ]
Williams, Keryn A. [2 ]
Voelcker, Nicolas H. [1 ]
机构
[1] Flinders Univ S Australia, Sch Chem & Phys Sci, Adelaide, SA, Australia
[2] Flinders Univ S Australia, Dept Ophthalmol, Adelaide, SA, Australia
基金
澳大利亚研究理事会; 英国医学研究理事会;
关键词
composite material; glaucoma; localized drug delivery; poly(L-lactide); porous silicon; uveitis; RING-OPENING POLYMERIZATION; FACTORS INFLUENCING RELEASE; CYCLODEXTRIN-COMPLEXATION; MESOPOROUS SILICON; L-LACTIDE; IN-VITRO; SURFACE; CAMPTOTHECIN; MECHANISM; HYDROGEL;
D O I
10.2217/NNM.11.176
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Aims: Porous silicon (pSi) and poly(L-lactide) (PLLA) both display good biocompatibility and tunable degradation behavior, suggesting that composites of both materials are suitable candidates as biomaterials for localized drug delivery into the human body. The combination of a pliable and soft polymeric material with a hard inorganic porous material of high drug loading capacity may engender improved control over degradation and drug release profiles and be beneficial for the preparation of advanced drug delivery devices and biodegradable implants or scaffolds. Materials & methods: In this work, three different pSi and PLLA composite formats were prepared. The first format involved grafting PLLA from pSi films via surface-initiated ring-opening polymerization (pSi PLLA [grafted]). The second format involved spin coating a PLLA solution onto oxidized pSi films (pSi PLLA [spin-coated]) and the third format consisted of a melt-cast PLLA monolith containing dispersed pSi microparticles (pSi PLLA [monoliths]). The surface characterization of these composites was performed via infrared spectroscopy, scanning electron microscopy, atomic force microscopy and water contact angle measurements. The composite materials were loaded with a model cytotoxic drug, camptothecin (CPT). Drug release from the composites was monitored via fluorimetry and the release profiles of CPT showed distinct characteristics for each of the composites studied. Results: In some cases, controlled CPT release was observed for more than 5 days. The PLLA spin coat on pSi and the PLLA monolith containing pSi microparticles both released a CPT payload in accordance with the Higuchi and Ritger-Peppas release models. Composite materials were also brought into contact with human lens epithelial cells to determine the extent of cytotoxicity. Conclusion: We observed that all the CPT containing materials were highly efficient at releasing bioactive CPT, based on the cytotoxicity data.
引用
下载
收藏
页码:995 / 1016
页数:22
相关论文
共 50 条
  • [1] Nanostructured poly(L-lactide) matrix as novel platform for drug delivery
    Zhou, Jianzhi
    Han, Songling
    Dou, Yin
    Lu, Ju
    Wang, Chenping
    He, Hongmei
    Li, Xiaohui
    Zhang, Jianxiang
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2013, 448 (01) : 175 - 188
  • [2] Porous poly(L-lactide) membranes for guided tissue regeneration and drug delivery
    Lee, SJ
    Park, YJ
    Ha, SJ
    Kim, DK
    Yeom, HL
    Chung, CP
    23RD INTERNATIONAL SYMPOSIUM ON CONTROLLED RELEASE OF BIOACTIVE MATERIALS, 1996 PROCEEDINGS, 1996, : 232 - 233
  • [3] Fabrication of Electrospun Poly L-lactide and Curcumin Loaded Poly L-lactide Nanofibers for Drug Delivery
    Thangaraju, Elakkiya
    Srinivasan, Natarajan Thirupathur
    Kumar, Ramadhar
    Sehgal, Praveen Kumar
    Rajiv, Sheeja
    FIBERS AND POLYMERS, 2012, 13 (07) : 823 - 830
  • [4] Fabrication of electrospun Poly L-lactide and Curcumin loaded Poly L-lactide nanofibers for drug delivery
    Elakkiya Thangaraju
    Natarajan Thirupathur Srinivasan
    Ramadhar Kumar
    Praveen Kumar Sehgal
    Sheeja Rajiv
    Fibers and Polymers, 2012, 13 : 823 - 830
  • [5] Porous poly(L-lactide) membranes for guided tissue regeneration and controlled drug delivery: Membrane fabrication and characterization
    Park, YJ
    Nam, KH
    Ha, SJ
    Pai, CM
    Chung, CP
    Lee, SJ
    JOURNAL OF CONTROLLED RELEASE, 1997, 43 (2-3) : 151 - 160
  • [6] Synthesis and drug controlled release of block copolymers of poly(L-lactide) with poly(D,L-lactide) and related monomers
    Feng, XD
    Jia, Y
    MACROMOLECULAR SYMPOSIA, 1997, 118 : 625 - 630
  • [7] Processing and properties of porous poly(L-lactide)/bioactive glass composites
    Zhang, K
    Wang, YB
    Hillmyer, MA
    Francis, LF
    BIOMATERIALS, 2004, 25 (13) : 2489 - 2500
  • [8] Preparation of porous composites consisting of apatite and poly(D,L-lactide)
    Nagata, F
    Miyajima, T
    Yokogawa, Y
    BIOCERAMICS 15, 2003, 240-2 : 167 - 170
  • [9] Nonisothermal crystallization of poly(L-lactide) in poly(L-lactide)/olive stone flour composites
    Jozic, Sanja Perinovic
    Jozic, Drazan
    Erceg, Matko
    Andricic, Branka
    Bernstorff, Sigrid
    THERMOCHIMICA ACTA, 2020, 683
  • [10] Drug release from poly(D, L-lactide) SiO2 composites
    Vaahtio, M
    Jokinen, M
    Rosling, A
    Kortesuo, P
    Kiesvaara, J
    Yli-Urpo, A
    BIOCERAMICS, VOL 16, 2004, 254-2 : 489 - 492